Back

Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Lipids and metabolism Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Arief Rahadian

Dian Nuswantoro University, Semarang (Indonesia)

11 More presentations in this session

Presentation thumbnail
Atheroprotective effects of 17beta-estradiol are mediated by PPARgamma in human coronary artery smooth muscle cells
Doctor J. Jehle (Bonn, DE)
Abstract
Presentation thumbnail
Shear stress induced unfolding of von willebrand factor may be involved in the premature development of myocardial infarction
Mr I. Melnikov (Moscow, RU)
Abstract Slides
Presentation thumbnail
A novel CD147 inhibitor SP-8356 attenuates plaque progression and stabilizes vulnerable plaque in ApoE-deficient mice
Doctor K. Pahk (Seoul, KR)
Abstract
Presentation thumbnail
Antibody treatment against pathological pancreatic islet amyloid polypeptide (IAPP) aggregates restores endothelial dysfunction in human-IAPP transgenic rats
Doctor A. Taheri (Zurich, CH)
Abstract
Presentation thumbnail
Molecular genetics of familial hypercholesterolemia in Israel revisited
Doctor R. Durst (Jerusalem, IL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Lipids and metabolism

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources